Renal association clinical practice guideline on Anaemia of Chronic Kidney Disease - PubMed (original) (raw)
Review
Renal association clinical practice guideline on Anaemia of Chronic Kidney Disease
Ashraf Mikhail et al. BMC Nephrol. 2017.
Abstract
Anaemia is a commonly diagnosed complication among patients suffering with chronic kidney disease. If left untreated, it may affect patient quality of life. There are several causes for anaemia in this patient population. As the kidney function deteriorates, together with medications and dietary restrictions, patients may develop iron deficiency, resulting in reduction of iron supply to the bone marrow (which is the body organ responsible for the production of different blood elements). Chronic kidney disease patients may not be able to utilise their own body's iron stores effectively and hence, many patients, particularly those receiving haemodialysis, may require additional iron treatment, usually provided by infusion.With further weakening of kidney function, patients with chronic kidney disease may need additional treatment with a substance called erythropoietin which drives the bone marrow to produce its own blood. This substance, which is naturally produced by the kidneys, becomes relatively deficient in patients with chronic kidney disease. Any patients will eventually require treatment with erythropoietin or similar products that are given by injection.Over the last few years, several iron and erythropoietin products have been licensed for treating anaemia in chronic kidney disease patients. In addition, several publications discussed the benefits of each treatment and possible risks associated with long term treatment. The current guidelines provide advice to health care professionals on how to screen chronic kidney disease patients for anaemia, which patients to investigate for other causes of anaemia, when and how to treat patients with different medications, how to ensure safe prescribing of treatment and how to diagnose and manage complications associated with anaemia and the drugs used for its treatment.
Conflict of interest statement
Competing interests
All authors made declarations of interest in line with the policy in the Renal Association Clinical Practice Guidelines Development Manual. Further details can be obtained on request from the Renal Association.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Similar articles
- Association of anaemia in primary care patients with chronic kidney disease: cross sectional study of quality improvement in chronic kidney disease (QICKD) trial data.
Dmitrieva O, de Lusignan S, Macdougall IC, Gallagher H, Tomson C, Harris K, Desombre T, Goldsmith D. Dmitrieva O, et al. BMC Nephrol. 2013 Jan 25;14:24. doi: 10.1186/1471-2369-14-24. BMC Nephrol. 2013. PMID: 23351270 Free PMC article. Clinical Trial. - Renal Association Clinical Practice Guideline on anaemia of chronic kidney disease.
Mikhail A, Shrivastava R, Richardson D. Mikhail A, et al. Nephron Clin Pract. 2011;118 Suppl 1:c101-24. doi: 10.1159/000328063. Epub 2011 May 6. Nephron Clin Pract. 2011. PMID: 21555890 No abstract available. - Anaemia management in patients with chronic kidney disease: Taiwan practice guidelines.
Hung SC, Kuo KL, Tarng DC, Hsu CC, Wu MS, Huang TP. Hung SC, et al. Nephrology (Carlton). 2014 Dec;19(12):735-9. doi: 10.1111/nep.12332. Nephrology (Carlton). 2014. PMID: 25156587 Review. - International treatment guidelines for anaemia in chronic kidney disease - what has changed?
Macginley RJ, Walker RG. Macginley RJ, et al. Med J Aust. 2013 Jul 22;199(2):84-5. doi: 10.5694/mja13.10538. Med J Aust. 2013. PMID: 23879487 No abstract available. - Practical approach to the diagnosis and treatment of anemia associated with CKD in elderly.
Agarwal AK. Agarwal AK. J Am Med Dir Assoc. 2006 Nov;7(9 Suppl):S7-S12; quiz S17-21. doi: 10.1016/j.jamda.2006.09.005. J Am Med Dir Assoc. 2006. PMID: 17098634 Review.
Cited by
- Development and validation of a nomogram to estimate fatigue probability in hemodialysis patients.
Qiao X, Zhan Y, Li L, Cui R. Qiao X, et al. Ren Fail. 2024 Dec;46(2):2396460. doi: 10.1080/0886022X.2024.2396460. Epub 2024 Sep 5. Ren Fail. 2024. PMID: 39238156 Free PMC article. - Prevalence, risk factors, and treatment of anemia in hospitalized older patients across geriatric and nephrological settings in Italy.
Soraci L, de Vincentis A, Aucella F, Fabbietti P, Corsonello A, Arena E, Aucella F, Gatta G, Incalzi RA. Soraci L, et al. Sci Rep. 2024 Aug 24;14(1):19721. doi: 10.1038/s41598-024-70644-8. Sci Rep. 2024. PMID: 39181939 Free PMC article. - Anaemia and quality of life in chronic kidney disease: a consensus document from the European Anaemia of CKD Alliance.
Dasgupta I, Bagnis CI, Floris M, Furuland H, Zurro DG, Gesualdo L, Heirman N, Minutolo R, Pani A, Portolés J, Rosenberger C, Alvarez JES, Torres PU, Vanholder RC, Wanner C; European Anaemia of aCKD Alliance. Dasgupta I, et al. Clin Kidney J. 2024 Jul 4;17(8):sfae205. doi: 10.1093/ckj/sfae205. eCollection 2024 Aug. Clin Kidney J. 2024. PMID: 39135937 Free PMC article. Review. - A cross-sectional study on the impact of hemodialysis duration on retinal nerve fiber layer thinning in hemodialysis patients.
Hong Y, Lan L, Hu X, Zuo Y, Deng M, Ye K, Xu F, Chen C, Li M. Hong Y, et al. Sci Rep. 2024 Aug 1;14(1):17824. doi: 10.1038/s41598-024-68589-z. Sci Rep. 2024. PMID: 39090115 Free PMC article. - Investigation and management of iron deficiency anaemia in a specialist palliative care setting and the role of intravenous iron: a descriptive analysis of hospice data.
Steele T, Bonwick H, Nwosu AC, Chapman L. Steele T, et al. AMRC Open Res. 2021 Mar 22;3:6. doi: 10.12688/amrcopenres.12963.2. eCollection 2021. AMRC Open Res. 2021. PMID: 38708071 Free PMC article.
References
- Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924–926. doi: 10.1136/bmj.39489.470347.AD. - DOI - PMC - PubMed
- National Collaborating Centre for Chronic Conditions, Royal College of Physicians. Guideline on anaemia management in chronic kidney disease. 2015. National Institute for Clinical Excellence. Available on http://www.nice.org.uk/guidance/NG8/evidence. Accessed 15 June 2017.
- National Collaborating Centre for Chronic Conditions, Royal College of Physicians. Guideline on chronic kidney disease in adults: assessment and management 2014. National Institute for Clinical Excellence. Available on http://www.nice.org.uk/guidance/cg182. Accessed 15 June 2017.
- Locatelli F, Aljama P, Barany P, et al. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. NephrolDialTransplant. 2004;19(Suppl 2):ii1–i47. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials